---
document_datetime: 2025-03-03 14:09:16
document_pages: 12
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/endolucinbeta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: endolucinbeta-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 19.5836065
conversion_datetime: 2025-12-28 19:21:01.878839
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## EndolucinBeta

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                             | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|---------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0039              | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation    | 26/02/2025                          |                                             | SmPC and PL                      |           |
| IA/0038/G            | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release | 19/11/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | Replacement/addition of a site where batch control/testing takes place B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS      |            |     |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10391 /202312 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                                                 | 05/09/2024 | n/a | PRAC Recommendation - maintenance |
| IAIN/0037           | B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer                                                                                                                                                                                                                          | 20/08/2024 | n/a |                                   |
| IB/0035/G           | This was an application for a group of variations. B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process | 03/04/2024 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|           | the AS - Change in immediate packaging of the AS Liquid ASs (non sterile) - Change in immediate packaging of the AS Liquid ASs (non sterile)                                                                                                                                                                                                                                                                                                                                                                |            |     | of B.I.c.1.c - B.I.c.1.c -   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------------|
| IB/0033/G | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure | 11/10/2023 | n/a | (including replacement       |
| IA/0034   | B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                                                                                                                                                                                                                                                                                                                                                         | 26/09/2023 | n/a |                              |
| IB/0032/G | This was an application for a group of variations. B.I.a.4.b - Change to in-process tests or limits applied during the manufacture of the AS - Addition of a new in-process test and limits B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other test procedure (including replacement                                                                                                                                                                             | 17/07/2023 | n/a | changes to a                 |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate B.I.a.4.z - Change to in-process tests or limits applied during the manufacture of the AS - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                            |            |     | or addition) for the   |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|
| IA/0031   | B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a State                                                                                                                                                                                                                                                                                                                                 | 29/05/2023 | n/a | Member                 |
| IB/0030/G | This was an application for a group of variations. B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation | 06/05/2022 | n/a |                        |

<div style=\"page-break-after: always\"></div>

| IB/0028   | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 29/04/2022   | n/a   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0029   | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 07/03/2022   | n/a   |
| IA/0027/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size | 15/02/2022   | n/a   |
| IB/0026/G | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 22/09/2021   | n/a   |

<div style=\"page-break-after: always\"></div>

|                     | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.2.c - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure for a reagent, which does not have a significant effect on the overall quality of the AS B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits   |            |     |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------------------|
| PSUSA/10391 /202012 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         | 08/07/2021 | n/a | PRAC Recommendation - maintenance |
| IA/0025/G           | This was an application for a group of variations. B.III.2.b - Change to comply with Ph. Eur. or with a national pharmacopoeia of a Member State - Change to comply with an update of the relevant monograph of the Ph. Eur. or national pharmacopoeia of a Member State B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch                                               | 18/06/2021 | n/a |                                   |

<div style=\"page-break-after: always\"></div>

|             | - Changes in the manufacturing process of AS - Minor change in the manufacturing process the AS                                                                                                                                                                                                                                                                                    |            |     | B.I.a.2.a the of       |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------------------------|
| IB/0022/G   | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement or addition) for the AS or a starting material/intermediate B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure or addition)    | 31/03/2021 | n/a | (including replacement |
| IAIN/0023/G | This was an application for a group of variations. B.I.a.1.a - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The proposed manufacturer is part of the same pharmaceutical group as the currently approved manufacturer B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS | 10/03/2021 | n/a |                        |
| IB/0020     | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                               | 09/02/2021 | n/a |                        |
| IA/0021/G   | This was an application for a group of variations.                                                                                                                                                                                                                                                                                                                                 | 08/02/2021 | n/a |                        |

<div style=\"page-break-after: always\"></div>

|                     | B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure                                         |            |            |                                  |                                                                                                                                                                                                                                                                             |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| R/0019              | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                  | 10/12/2020 | 08/02/2021 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of EndolucinBeta in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/10391 /201912 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                  | 23/07/2020 | 24/09/2020 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10391/201912.                                                                                                                                  |
| IB/0017             | B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition)                                                                                                                                                   | 05/08/2020 | n/a        |                                  |                                                                                                                                                                                                                                                                             |
| IB/0016/G           | This was an application for a group of variations. B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS | 15/07/2020 | n/a        |                                  |                                                                                                                                                                                                                                                                             |
| IAIN/0018/G         | This was an application for a group of variations. A.1 - Administrative change - Change in the name                                                                                                                                                                                      | 29/06/2020 | 24/09/2020 | SmPC, Annex II, Labelling        |                                                                                                                                                                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|                     | and/or address of the MAH A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release            |            |            | and PL      |                                                                                                                                            |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0015             | B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                                               | 25/05/2020 | n/a        |             |                                                                                                                                            |
| IB/0013/G           | This was an application for a group of variations. B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Other variation | 06/12/2019 | n/a        |             |                                                                                                                                            |
| PSUSA/10391 /201812 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                      | 25/07/2019 | 23/09/2019 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10391/201812. |
| IA/0012/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of                                                                                                                                                                                                                                                                                                       | 11/09/2019 | n/a        |             |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|                     | the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)   |            |            |             |                                                                                                                                            |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0011/G           | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure                                                                                                                                                                                  | 29/05/2019 | n/a        |             |                                                                                                                                            |
| PSUSA/10391 /201806 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                                                                                              | 31/01/2019 | 28/03/2019 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10391/201806. |
| IB/0009             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                                                                                        | 18/02/2019 | n/a        |             |                                                                                                                                            |
| PSUSA/10391 /201712 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                                                                                              | 26/07/2018 | 20/09/2018 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for                     |

<div style=\"page-break-after: always\"></div>

|                     |                                                                                                                                                                                                                                                                                                                                                                                                                          |            |            |             | PSUSA/10391/201712.                                                                                                                        |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10391 /201706 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                                  | 25/01/2018 | 27/03/2018 |             | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10391/201706. |
| IB/0006             | B.I.a.1.z - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Other variation                                                                                                                                                                                                                                                                                                     | 21/02/2018 | n/a        |             |                                                                                                                                            |
| IB/0005             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                                                                                                                                                                                                            | 06/01/2018 | n/a        |             |                                                                                                                                            |
| PSUSA/10391 /201612 | Periodic Safety Update EU Single assessment - lutetium (177Lu) chloride                                                                                                                                                                                                                                                                                                                                                  | 20/07/2017 | 21/09/2017 | SmPC and PL | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10391/201612. |
| IA/0003/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 28/07/2017 | n/a        |             |                                                                                                                                            |
| IB/0002             | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                                                                                                                                                                                                               | 24/05/2017 | n/a        |             |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

<!-- image -->